Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Clinical trial NCT06573294 · TERMINATED

Trial details

NCT number: NCT06573294
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors Metastatic Malignant Solid Tumors

Start date: 2024-08-28
Primary completion: 2026-04-07
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.